Hemay Pharma Completes Series D Financing for Autoimmune and Oncology Drugs
China-based Ganzhou Hemay Pharmaceutical Co., Ltd, an innovative drug developer focused on autoimmune diseases and...
Gastroenterology
ConceMed Raises Pre-Series A Funding to Expand Digestive Endoscope Pipeline
ConceMed, a Guangdong-based maker of digestive soft electronic endoscopes, has reportedly raised “tens of millions”...
Fosun Pharma Signs Exclusive Licensing Deal for H008 with Carephar
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has signed an exclusive...
NMPA Reclassifies Omeprazole Tablets from Prescription to OTC Status
The National Medical Products Administration (NMPA) announced that omeprazole enteric-coated tablets have been reclassified from...
Eccogene Receives FDA Approval for ECC4703 Phase I Study in NASH and Dyslipidemia
Shanghai-based biopharmaceutical company Eccogene announced it has received approval from the U.S. Food and Drug...
Triastek Partners with Eli Lilly to Explore 3D Printing for GI Drug Delivery
China-based Triastek Inc., a pharmaceutical 3D printing specialist, announced a partnership with US firm Eli...
Innovent Biologics Doses First Patient in IBI112 Phase II Study for Ulcerative Colitis
China-based Innovent Biologics, Inc. (HKG: 1801) announced the successful first patient dosing in a Phase...
Ferring and I-Mab Expand Olamkicept Collaboration for Inflammatory Diseases
Swiss pharmaceutical company Ferring Pharmaceuticals has announced a strategic collaboration with China’s I-Mab Inc. (NASDAQ:...